Extracorporeal Membrane Oxygenation Machine Market

Extracorporeal Membrane Oxygenation (ECMO) Machine is a life support machine used as a heart-lung bypass in cases of critical damage to the heart and lungs. The ECMO machine is used to pump and oxygenate patient’s blood outside the body and allows the heart and lungs to rest. When a patient is connected to an ECMO machine, the blood flows through tubes to an artificial lung, wherein oxygen is added and carbon dioxide is removed from the blood. This blood is then warmed to body temperature and pumped back into the patient’s body.

The ECMO machines play a vital role during intensive care in conditions when the lung cannot provide enough oxygen to the blood, when lungs cannot remove carbon dioxide from the blood even with the help of ventilator, and when heart cannot pump sufficient blood to the body. Increasing number of patients suffering with cardiovascular and lung disorders has increased the fatality rate due to these disorders. The demand for extracorporeal membrane oxygenation (ECMO) machine is expected to rise in coming years owing to focused efforts to reduce the mortality rate due to lung and cardiac failure.

North America contributed the largest share to the global extracorporeal membrane oxygenation machine market in 2019 and is anticipated to be the dominating geography throughout the forecast period. Rising number of patient suffering with cardiorespiratory disorders and presence of key manufacturers of ECMO machines are the key factor fueling the growth of ECMO machine market in North America. Asia Pacific ECMO machine market is anticipated to witness lucrative growth during the forecast period owing to focused healthcare infrastructure development activities and increasing number of patients with cardiorespiratory disorders.

The report titled “Extracorporeal Membrane Oxygenation Machine Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global extracorporeal membrane oxygenation machine market.

Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Medtronic plc reported revenues of USD 30,557 million in 2019 and the product segment analysis of the company indicates that Cardiac & Vascular business segment of the company dominated revenue in 2019.

The global extracorporeal membrane oxygenation machine market is segmented based on component, modality type, application, patient type, and geography. Based on component, the global extracorporeal membrane oxygenation machine market is segmented into pumps, oxygenators, controllers, cannula, and accessories. Based on modality type, the global extracorporeal membrane oxygenation machine market is segmented into veno-arterial, veno-venous, and others. Based on application, the global extracorporeal membrane oxygenation machine market is segmented into respiratory, cardiac, extracorporeal cardiopulmonary resuscitation (ECPR), and others. Based on patient type, the global extracorporeal membrane oxygenation machine market is segmented into neonates, pediatric, and adult. Based on geography, the global extracorporeal membrane oxygenation machine market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The research would provide in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on extracorporeal membrane oxygenation machine. Market share of prominent companies in the global extracorporeal membrane oxygenation machine market would be included.

For instance, Medtronic plc operates through four business divisions namely Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The extracorporeal membrane oxygenation machines are delivered under Cardiac & Vascular Group of the company with revenue contribution of US$ 11,505 million in 2019. 

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the extracorporeal membrane oxygenation machine companies. Furthermore, the global extracorporeal membrane oxygenation machine market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.

Product portfolio would focus on all the products under the extracorporeal membrane oxygenation machine market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global extracorporeal membrane oxygenation machine market.

Major players active in the global extracorporeal membrane oxygenation machine market include MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Medtronic plc, Microport Scientific Corporation, Nipro Medical Corporation, Sorin Group, and Terumo Cardiovascular Systems Corporation.

Market Segmentation: